CVS (NYSE: CVS) has entered the in-home dialysis market. The company announced Wednesday it is beginning a clinical trial of its new home hemodialysis system this week. By enabling in-home treatment, CVS could allow patients with end-stage kidney disease to receive more frequent care, with the goal being to improve outcomes. Typically, patients with kidney […]
UBS
Subscribe
Receive industry updates and breaking news from HHCN